Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Shares Outstanding (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Shares Outstanding data on record, last reported at $51.9 million in Q4 2025.

  • For Q4 2025, Shares Outstanding rose 7.36% year-over-year to $51.9 million; the TTM value through Dec 2025 reached $51.9 million, up 7.36%, while the annual FY2025 figure was $51.9 million, 7.36% up from the prior year.
  • Shares Outstanding reached $51.9 million in Q4 2025 per MIRM's latest filing, up from $51.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $51.9 million in Q4 2025 and bottomed at $30.2 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $41.1 million, with a median of $42.4 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: increased 2.71% in 2021, then rose 26.57% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $30.6 million in 2021, then rose by 20.84% to $37.0 million in 2022, then increased by 26.43% to $46.7 million in 2023, then rose by 3.46% to $48.3 million in 2024, then grew by 7.36% to $51.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $51.9 million in Q4 2025, $51.3 million in Q3 2025, and $50.1 million in Q2 2025.